Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 91.07 USD 1.35%
Market Cap: 134.2B USD
Have any thoughts about
Boston Scientific Corp?
Write Note

Boston Scientific Corp
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Boston Scientific Corp
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Boston Scientific Corp
NYSE:BSX
Long-Term Investments
$532m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Edwards Lifesciences Corp
NYSE:EW
Long-Term Investments
$319.6m
CAGR 3-Years
-37%
CAGR 5-Years
-4%
CAGR 10-Years
13%
Stryker Corp
NYSE:SYK
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Long-Term Investments
$912m
CAGR 3-Years
4%
CAGR 5-Years
1%
CAGR 10-Years
15%
Intuitive Surgical Inc
NASDAQ:ISRG
Long-Term Investments
$4.1B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
13%
No Stocks Found

Boston Scientific Corp
Glance View

Market Cap
134.2B USD
Industry
Health Care
Economic Moat
Narrow

In the world of medical devices, Boston Scientific Corp. has carved out a significant niche, navigating the intersection of innovation and healthcare with precision. Founded in 1979, the company has built a robust reputation for developing a diverse range of products that address complex medical conditions. Boston Scientific operates through various segments, primarily focusing on interventional medical specialties that target areas such as cardiology, endoscopy, and neuromodulation. Through its relentless pursuit of innovation, the company continues to push boundaries, enhancing the diagnostic and therapeutic capabilities of physicians worldwide. The heartbeat of its operations lies in its extensive research and development endeavors, where cutting-edge technology meets advanced medical knowledge to produce life-enhancing solutions. At its core, Boston Scientific makes money by designing, manufacturing, and selling medical devices used in minimally invasive procedures. Its product portfolio includes solutions for coronary artery disease, heart rhythm disorders, peripheral artery disease, and many other critical ailments. By partnering with healthcare providers, Boston Scientific enables hospitals and clinics to offer high-quality, efficient care that caters to patient needs in a cost-effective manner. Revenue streams flow through direct sales channels and strategic partnerships across global markets, reflecting a combination of organic growth and strategic acquisitions. Moreover, the company actively reinvests in future technologies, ensuring its position as a pioneer in medical advancements while meeting the ever-evolving demands of the industry.

BSX Intrinsic Value
63.13 USD
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Boston Scientific Corp's Long-Term Investments?
Long-Term Investments
532m USD

Based on the financial report for Sep 30, 2024, Boston Scientific Corp's Long-Term Investments amounts to 532m USD.

What is Boston Scientific Corp's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
7%

Over the last year, the Long-Term Investments growth was 25%. The average annual Long-Term Investments growth rates for Boston Scientific Corp have been 7% over the past three years .

Back to Top